Juniper announces enrollment of first patient in COL-1077 Phase II trial to...
Juniper Pharmaceuticals, Inc., a specialty pharmaceutical company focused on the development of therapeutics for women's health, announced today the first patient has been enrolled in a Phase II...
View ArticleCRI commits $29.3 million in new funds to accelerate development of cancer...
The Cancer Research Institute, a nonprofit organization dedicated to fueling the discovery and development of immunotherapies for all forms of cancer, announced that it has committed more than $29.3...
View ArticleNew study describes multi-method strategy to improve detection of PMS2 gene...
About 3% of colorectal cancers are due to Lynch syndrome, an inherited cancer susceptibility syndrome that predisposes individuals to various cancers. Close blood relatives of patients with Lynch...
View ArticleUVA researchers identify new strategy for attacking cancer cells
University of Virginia School of Medicine researchers have discovered a new strategy for attacking cancer cells that could fundamentally alter the way doctors treat and prevent the deadly disease. By...
View ArticleResearchers discover new strategy for attacking cancer cells
University of Virginia School of Medicine researchers have discovered a new strategy for attacking cancer cells that could fundamentally alter the way doctors treat and prevent the deadly disease.
View ArticleEndocrine Society issues Clinical Practice Guideline on treatment of...
The Endocrine Society today issued a Clinical Practice Guideline (CPG) on identifying women who are candidates for treatment of menopausal symptoms and selecting the best treatment options for each...
View ArticleUndetected cancer among women undergoing gynecologic surgery more common than...
Minimally invasive gynecologic surgeries have advantages for patients, including shorter hospital stays, quicker recoveries, and less pain. However, power morcellation, a technique which cuts the...
View ArticleNew study shows wide disparities in access to minimally invasive...
A new study led by Johns Hopkins researchers shows wide racial and economic disparities in access to minimally invasive hysterectomies for early uterine cancer in the United States. This is despite...
View ArticleJohns Hopkins-led study shows disparities in access to minimally invasive...
A new study led by Johns Hopkins researchers shows wide racial and economic disparities in access to minimally invasive hysterectomies for early uterine cancer in the United States. This is despite...
View ArticleNew study finds familial risk and heritability of cancer among twins
A large new study of twins has found that having a twin sibling diagnosed with cancer poses an excess risk for the other twin to develop any form of cancer. Among the 23 different types of cancer...
View ArticlePredictive statistical approach opens door to development of more effective...
Designing effective new drugs, especially drugs to fight cancer, demands that you know as much as you can about the molecular workings of cancer growth. Without that, it's like planning to fight a war...
View ArticleMulti-center study may help reassure breast cancer patients taking tamoxifen...
A study led by Loyola Medicine researchers may help reassure patients who worry the breast cancer drug tamoxifen could increase their risk of uterine cancer.
View ArticleNLCs packed with melatonin could increase effectiveness of tamoxifen drug
Tiny bubbles filled with the sleep hormone melatonin can make breast cancer treatment more effective, which means people need a lower dose, giving them less severe side effects.
View ArticleWomen with BRCA1 gene mutation at increased risk of aggressive uterine cancer
Women who carry the BRCA1 gene mutation that dramatically increases their risk of breast and ovarian cancers are also at higher risk for a lethal form of uterine cancer, according to a study led by a...
View ArticleBiobank blood storage time may influence test results, study finds
The amount of time a blood sample used for medical research has been stored at a biobank may affect the test results as much as the blood sample provider's age.
View ArticleStudy may help reassure women who fear endometrial side effects of breast...
A study led by Loyola Medicine researchers may help reassure patients who worry the breast cancer drug tamoxifen could increase their risk of uterine cancer.
View ArticleSticky nanoparticles could play vital role in fighting cancers
Sticky nanoparticles that deliver drugs precisely to their targets — and then stay there — could play a crucial role in fighting ovarian and uterine cancers.
View ArticleTSRI scientists offer novel structure-based drug design strategy for better...
While there have been advances in the treatment of hormone-driven breast cancer, resistance to these therapies remains a significant problem.
View ArticleSurgery within first two weeks after diagnosis increases risk of death for...
Delaying surgery after a diagnosis of uterine cancer can increase a women's risk of death, but operating too soon can be just as detrimental for some, Penn Medicine physicians report in a new study...
View ArticleScientists uncover how tumor cells can switch disguises to spread easily...
Scientists have uncovered how tumor cells in aggressive uterine cancer can switch disguises and spread so quickly to other parts of the body.
View Article
More Pages to Explore .....